What is Kindstar Globalgene Technology Operating Cash Flow per Share?
Kindstar Globalgene Technology's operating cash flow per share for the
six
months ended in Dec. 2024 was HK$0.03.
Kindstar Globalgene Technology's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.05.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Kindstar Globalgene Technology's Operating Cash Flow per Share or its related term are showing as below:
During the past 7 years, Kindstar Globalgene Technology's highest 3-Year average Operating Cash Flow per Share Growth Rate was 35.20% per year. The lowest was -38.10% per year. And the median was -1.45% per year.
HKSE:09960's 3-Year OCF Growth Rate is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 3.35 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
Kindstar Globalgene Technology Operating Cash Flow per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Kindstar Globalgene Technology Operating Cash Flow per Share Chart
Competitive Comparison of Kindstar Globalgene Technology's Operating Cash Flow per Share
For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kindstar Globalgene Technology's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Kindstar Globalgene Technology's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kindstar Globalgene Technology Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Kindstar Globalgene Technology Business Description
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09960 has been successfully added to your 